Based on the Medibank Private Limited stock forecast from 0 analysts, the average analyst target price for Medibank Private Limited is not available over the next 12 months. Medibank Private Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Medibank Private Limited is Slightly Bearish, which is based on 6 positive signals and 8 negative signals. At the last closing, Medibank Private Limited’s stock price was EUR 2.22. Medibank Private Limited’s stock price has changed by -0.89% over the past week, -2.63% over the past month and +9.90% over the last year.
No recent analyst target price found for Medibank Private Limited
No recent average analyst rating found for Medibank Private Limited
Company Overview Medibank Private Limited
Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth services to government and corporate customers; and distributes travel, life, and pet insurance products. It underwrites its health insurance products under the Medibank and ahm brands. The company was founded in 1976 and is based in Docklands, Australia. Read Less
Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers m...Read More
Frequently Asked Questions About Medibank Private Limited (MPV:F) Stock
Stock Target Advisor's fundamental analysis for Medibank Private Limited's stock is Slightly Bearish.
MPV:F stock's dividend yield is 4.52%.
Our analysis grades MPV:F stock's dividend yield at B-. This means that MPV:F stock's dividend yield is above 80% of the stocks in the Insurance - Specialty sector in the F exchange.
Based on this MPV:F may be a good dividend stock for its sector.
Unfortunately we do not have enough data on MPV:F's stock to indicate what its average analyst target is.
MPV:F stock's Price/Earning ratio is 20.18.
Our analysis grades MPV:F stock's Price / Earning ratio at F. This means that MPV:F stock's Price/Earning ratio is above 89% of the stocks in the Insurance - Specialty sector in the F exchange.
Based on this MPV:F may be a overvalued for its sector.
The last closing price of MPV:F's stock was EUR 2.22.
The most recent market capitalization for MPV:F is EUR 6.30B.
Unfortunately we do not have enough analyst data on MPV:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Medibank Private Limited's stock.
As per our most recent records Medibank Private Limited has 3,220 Employees.
Medibank Private Limited's registered address is 695 Collins Street, Docklands, VIC, Australia, 3008.
You can get more information about it from Medibank Private Limited's website at https://www.medibank.com.au.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Medibank Private Limited (MPV:F) Stock
Stock Target Advisor's fundamental analysis for Medibank Private Limited's stock is Slightly Bearish.
MPV:F stock's dividend yield is 4.52%.
Our analysis grades MPV:F stock's dividend yield at B-. This means that MPV:F stock's dividend yield is above 80% of the stocks in the Insurance - Specialty sector in the F exchange.
Based on this MPV:F may be a good dividend stock for its sector.
Unfortunately we do not have enough data on MPV:F's stock to indicate what its average analyst target is.
MPV:F stock's Price/Earning ratio is 20.18.
Our analysis grades MPV:F stock's Price / Earning ratio at F. This means that MPV:F stock's Price/Earning ratio is above 89% of the stocks in the Insurance - Specialty sector in the F exchange.
Based on this MPV:F may be a overvalued for its sector.
The last closing price of MPV:F's stock was EUR 2.22.
The most recent market capitalization for MPV:F is EUR 6.30B.
Unfortunately we do not have enough analyst data on MPV:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Medibank Private Limited's stock.
As per our most recent records Medibank Private Limited has 3,220 Employees.
Medibank Private Limited's registered address is 695 Collins Street, Docklands, VIC, Australia, 3008.
You can get more information about it from Medibank Private Limited's website at https://www.medibank.com.au.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MPV:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
